TRIPZ-bioGEF-UBwt-PURO
(Plasmid
#208045)
-
PurposeEnables inducible expression of low-affinity Avitag-Ubwt; to perform bioE3; selection with puromycin
-
Depositing Labs
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 208045 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneTRIPZ
-
Backbone manufacturerOpen Biosystems
-
Vector typeLentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameUb
-
SpeciesH. sapiens (human)
-
Entrez GeneUBC (a.k.a. HMG20)
- Promoter tetO/UBC
-
Tag
/ Fusion Protein
- Low-affinity Avitag (N terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Lentiviral packaging of TRIPZ is more efficient with TAT expression (e.g using pcDNA1-TatHIV Addgene ID: 138478) and 2nd generation gag/pol/env combination (e.g. using PSPAX2 Addgene ID: 12260 and pMD2.G Addgene ID: 12259); Use of bioGEF-UBwt may be necessary for certain E3 ligases (e.g. NEDD4 HECT ligase); Use of "non-cleavable" versions may reduce recycling of biotinylated UB and may lead to higher yields of biotinylated protein for proteomic analysis, but induction times should be minimized to avoid toxicity.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
TRIPZ-bioGEF-UBwt-PURO was a gift from Rosa Barrio & James Sutherland (Addgene plasmid # 208045 ; http://n2t.net/addgene:208045 ; RRID:Addgene_208045) -
For your References section:
BioE3 identifies specific substrates of ubiquitin E3 ligases. Barroso-Gomila O, Merino-Cacho L, Muratore V, Perez C, Taibi V, Maspero E, Azkargorta M, Iloro I, Trulsson F, Vertegaal ACO, Mayor U, Elortza F, Polo S, Barrio R, Sutherland JD. Nat Commun. 2023 Nov 23;14(1):7656. doi: 10.1038/s41467-023-43326-8. 10.1038/s41467-023-43326-8 PubMed 37996419